As in vitro fertilization procedures evolve with new technologies and extended embryo care, embryologists face increasing workloads, higher stress levels, and the challenge of maintaining precision, leading to concerns about burnout and efficiency in the lab.
New research from NYU Grossman School of Medicine reveals that maternal health conditions during pregnancy are correlated with autism risk but are not a direct cause, highlighting the role of genetic and familial factors.
Discover how Mirvie’s RNA platform uses a simple blood test to detect fetal growth restriction early in pregnancy, allowing for proactive interventions and improved outcomes for mothers and babies.
Learn how carrier screening and noninvasive prenatal testing help expectant parents identify genetic risks early, explore reproductive options, and prepare for the best possible pregnancy outcomes.
Discover the latest advancements in prenatal genetic screening, the challenges preventing access, and how increased awareness can help expecting parents make informed decisions.
Discover how maternal fetal medicine specialists are tackling maternal mortality disparities through trust-building, diverse care teams, and comprehensive support programs.
The FDA-cleared and CLIA-waived cobas liat sexually transmitted infection multiplex assay panels offer rapid, point-of-care testing for chlamydia, gonorrhea, and mycoplasma genitalium.
Timely diagnosis of gestational diabetes is crucial for optimal maternal and fetal health, but a recent study highlights demographic disparities in screening delays and the need for further research on potential health impacts.
A new study links first-trimester hemorrhage and anemia to a higher placenta accreta spectrum risk, emphasizing early screening and non-traditional risk factors.
Learn how complex contraceptive counseling helps individuals with medical conditions such as heart disease, lupus, and breast cancer find safe, effective birth control options tailored to their unique needs.
Daniel L. Kuhr, MD, maternal fetal medicine fellow at Mount Sinai, discusses the role of neighborhood-level indices in predicting spontaneous preterm birth risk and why individual patient characteristics remain the key factor.
A new randomized control trial reveals that barbed sutures significantly reduce blood loss during hysterotomy, offering valuable insights for improving clinical outcomes in obstetric surgery.
A new study explores the potential link between antiretroviral therapy, specifically integrase inhibitors, and fetal biometric measurements, shedding light on possible pregnancy complications.
Artificial intelligence-powered ultrasound analysis is enhancing the early detection of congenital heart defects, improving diagnostic accuracy, physician confidence, and neonatal outcomes.
Dr. Ulla-Britt Wennerholm explores the risks and benefits of induction for prolonged pregnancies, highlighting new research on optimal gestational age and outpatient induction trials.
Discover how Sweden's national guidelines and early induction practices are improving outcomes for prolonged pregnancies, reducing stillbirths, and shaping global maternity care.
Discover updated strategies for treating leukemia and lymphomas during pregnancy, emphasizing delayed delivery, chemotherapy safety, and multidisciplinary care for optimal maternal and fetal health.
Discover how pre-implantation genetic diagnosis (PGD) helps predict and prevent miscarriages, improve IVF outcomes, and ensure healthier pregnancies.
A recent study reveals shifts in contraceptive preferences, highlighting increased use of natural family planning, declining reliance on hormonal methods, and the need for better access to reliable information.
A new study reveals that high radon exposure, especially when combined with smoking or air pollution, significantly raises the risk of gestational diabetes, highlighting the impact of environmental factors on maternal health.
A new study revealed disparities in menopause symptoms and care access between rural and urban women, highlighting the need for improved health equity and provider training.
Kameelah Phillips, MD, FACOG, NCMP, discusses how health care providers (HCPs) can empower patients to advocate for their health during cervical cancer and sexually transmitted infection (STI) screenings by building trust, fostering open communication about sensitive topics, and striking a balance between sensitivity and thorough screening practices.
Discover how MedStar Health’s Safe Baby Safe Moms program is scaling its proven maternal care model to support diverse communities across the DC and Maryland region.
Discover how MedStar Health's innovative program is improving outcomes and reducing disparities for mothers and children through tailored care and groundbreaking partnerships.
Discover how the updated 2024 American Society for Colposcopy and Cervical Pathology guidelines integrate extended human papillomavirus genotyping and precision medicine to enhance cervical cancer screening and risk management.
Discover how FDA-approved self-collection and updated guidelines for cervical cancer screening are improving accessibility and empowering early prevention efforts.
Jeff Andrews, MD, FRCSC, discusses troubling trends in cervical cancer mortality and how self-collection could address key barriers to screening, based on a recent BD survey conducted across 4 countries.
The panelist discusses the cautions around recent FDA approvals on human papillomavirus (HPV) self-collection, including limitations and sensitivity while emphasizing the importance of patients continuing to see their OB/GYN regularly.
Kameelah Phillips, MD, FACOG, NCMP, discusses how cervical cancer remains a significant health concern, emphasizing current incidence and prevalence rates, the critical importance of regular screenings in early detection and prevention, and the recommended guidelines for cervical cancer screening during well-woman visits.
This week the panel weighs in on monoclonal antibodies in this patient population as well as important overall takeaways about COVID-19 therapies.
